News

UMCs strengthen research and innovation in the region

- Vanmorgen heeft prof. dr. Willy Spaan, voorzitter van de Nederlandse Federatie van Universitair Medische Centra (NFU) het plan ‘Onderzoek & Innovatie met en voor de gezonde regio’ overhandigd aan minister Bruins (Medische zorg). Het plan schetst een verbindende rol van de universitair medische centra (umc’s) in het oplossen van gezondheidsvraagstukken dicht bij huis.

IDE Group Opens European Headquarters in the Netherlands

- Australian product innovation agency IDE Group recently opened its new European headquarters in Rotterdam, from where it will serve its European partners. IDE Group develops medical technology innovations in partnership with life sciences companies and technical universities.

Submit your private investments in R&D this Spring

- If you are a company investing in R&D in the Netherlands or working at a research organisation that receives private investments for your R&D, you can submit these projects via the Top Sector LSH! For every submitted €1 we receive €0,30 which will be invested in new public-private partnerships! Interested in this funding opportunity?

Micreos raises €30 million for endolysin technology set to replace antibiotics

- Dutch biotechnology company Micreos announced it has secured €30 million in funding to accelerate the development of its endolysin technology, set to replace antibiotics. Proceeds are earmarked for the clinical development program of its endolysin XZ.700 and the USA launch of its breakthrough OTC Gladskin product for eczema.

Mona Keijzer announces new Life Sciences & Health national action programme

- During the EMA symposium of the Dutch Association of Pharmaceutical Medicine (NVFG) on February 5 in Amsterdam, the Dutch State Secretary of Economic Affairs and Climate Policy, Mona Keijzer, announced the launch of the ‘National Action Programme European Medicines Agency', which will ensure the Netherlands gains optimal results from the recent arrival of the EMA.

ProQR spins out all Dystrophic Epidermolysis Bullosa activities into newly formed Wings Therapeutics

- ProQR Therapeutics, a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases, announced the strategic spin out of the Dystrophic Epidermolysis Bullosa (DEB) activities into the newly formed company, Wings Therapeutics.

Pacmed and Amsterdam UMC will improve IC care with machine learning

- Pacmed en Amsterdam UMC hebben een langdurige samenwerkingsovereenkomst getekend. Het doel is om samen de zorg voor patiënten op de Intensive Care (IC) te blijven verbeteren met behulp van big data en machine learning.

New research explores the effect of nutrition on the fitness of the immune system

- The 26th of March marks the start of four scientific projects that will investigate the effects of nutrition on the fitness of the immune system. The scientists received funding for these projects from the Partnership programme of NWO Domain Applied and Engineering Sciences and Danone Nutricia Research. NWO and Danone Nutricia Research are investing a total of 3 million Euros in this programme.

Create2Solve- Request for Challenges

- Loopt jouw organisatie tegen uitdagingen aan in de ontwikkeling of toepassing van diervrije innovaties? Reageer dan voor 23 april op de Create2Solve-oproep van het ZonMw programma Meer Kennis met Minder Dieren. Dien je “Challenge” in en wie weet broeden onderzoeksinstellingen en MKB straks op jouw innovatieve, diervrije oplossing.

Meet the Dutch at BIO-Europe Spring 2019 in Vienna

- BIO-Europe Spring will go to Vienna, Austria, March 25 - 27, 2019. BIO-Europe Spring is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe, and continues the tradition of providing life science companies with high caliber partnering opportunities. At BIO-Europe Spring, you can ignite powerful partnerships with global life sciences leaders via PartneringONE, attend 20 workshops and panels, and network with 2,400+ attendees from 55 countries.